Development of the Health and Nutrition Business
First written in FY2016. 21 of 26 entries say "Advanced", first in FY2017. Latest entry: 2026-08-07.
8 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Health foods sold through the e-commerce channel in the growth areas performed steadily, and profit also benefited from higher earnings at proprietary operating companies and other entities.」
The company disclosed sales trends in the growth areas, including health foods sold through its e-commerce channel. Revenue in the growth and other areas was ¥81,965 million. - FY2026-H1AdvancedAnnual report
「Health foods sold through the e-commerce channel in the growth areas performed steadily, and profit also benefited from higher earnings at proprietary operating companies and other entities. Growth and other areas revenue was ¥47,882 million (up 5.8% year on year), and operating profit was ¥1,436 million (up ¥989 million from the previous year).」
Businesses in the growth areas, including e-commerce sales of health foods, performed steadily, resulting in higher revenue and profit in the growth and other areas. - FY2025-H1The nutrition and functional foods business posted higher revenue but lower profit.Annual report
「① Nutrition and functional foods business: Yogurt performed steadily, led by "Bifidus Yogurt" against a backdrop of growing health consciousness, while the company continued to focus on expanding functional yogurt and products such as "Partheno." The business as a whole posted higher revenue, partly due to contributions from Morinaga Milk Industry クリニコ, which handles nutritional foods such as infant formula and enteral nutrition. On the profit side, although the company worked to improve its product mix and reduce costs in response to higher raw material prices and operating costs, profit for the business as a whole declined due partly to higher sales promotion expenses and other costs.」
Expanded sales of "Bifidus Yogurt," functional yogurt, "Partheno," infant formula and クリニコ's enteral nutrition products resulted in revenue of ¥64,977 million, up 2.1% year on year, while operating profit was ¥3,031 million, down ¥999 million from the previous year. - FY2024AdvancedAnnual report
「Nutrition and functional foods business: In addition to implementing price revisions for yogurt, the company continued to focus on expanding functional yogurt, with "Bifidus Yogurt" and "Partheno" performing steadily against a backdrop of growing health consciousness. The business as a whole posted higher revenue, partly due to contributions from Morinaga Milk Industry クリニコ, which handles nutritional foods such as infant formula and enteral nutrition.」
The nutrition and functional foods business expanded functional yogurt, infant formula and enteral nutrition, generating revenue of ¥127,281 million. However, operating profit declined due to increased promotional spending and higher costs. - FY2024-Q3AdvancedAnnual report
「Nutrition and functional foods business: In addition to implementing price revisions for yogurt, the company continued to focus on expanding functional yogurt, with "Bifidus Yogurt" and "Partheno" performing steadily against a backdrop of growing health consciousness. The business as a whole posted higher revenue, partly due to contributions from クリニコ, which handles nutritional foods such as infant formula and enteral nutrition.」
The nutrition and functional foods business expanded functional yogurt, infant formula and クリニコ's enteral nutrition products, generating revenue of ¥96,812 million, up 2.8% year on year, and operating profit of ¥6,183 million. - FY2024-Q2AdvancedAnnual report
「Nutrition and functional foods business revenue ¥63,614 million (up 2.7% year on year) Nutrition and functional foods business operating profit ¥4,030 million (up ¥562 million from the previous year)」
The nutrition and functional foods business posted higher revenue and profit, driven by the expansion of functional yogurt, infant formula and enteral nutrition, as well as price revisions and an improved product mix. - FY2024-Q1AdvancedAnnual report
「Nutrition and functional foods business: In addition to implementing price revisions for yogurt, the company continued to focus on expanding functional yogurt against a backdrop of growing health consciousness, with "Bifidus Yogurt for Improved Bowel Movements" performing particularly steadily. The business as a whole posted higher revenue, partly due to contributions from クリニコ, which handles nutritional foods such as infant formula and enteral nutrition.」
The nutrition and functional foods business expanded functional yogurt, infant formula and クリニコ's enteral nutrition products, generating revenue of ¥31,991 million and operating profit of ¥1,966 million. - FY2023-Q3AdvancedAnnual report
「Yogurt revenue increased as products including "Bifidus Yogurt for Improved Bowel Movements" performed steadily. Revenue also increased at クリニコ, which handles enteral nutrition and other products, resulting in higher revenue for the business as a whole.」
Driven by higher revenue at functional yogurt and クリニコ, revenue in the nutrition and functional foods business was ¥94,221 million, up 0.4% year on year. However, operating profit was ¥4,794 million, down ¥3,244 million from the previous year due to higher raw material and energy prices. - FY2023-Q2AdvancedAnnual report
「Yogurt revenue increased as products including "Bifidus Yogurt for Improved Bowel Movements" performed steadily. Revenue also increased at クリニコ, which handles enteral nutrition and other products.」
Although sales of functional yogurt and クリニコ expanded, profit in the nutrition and functional foods business as a whole declined due to higher raw material and energy prices. - FY2022AdvancedAnnual report
「Wellness business revenue: ¥44,218 million (up 2.7% year on year) Wellness business operating profit: ¥3,780 million (up ¥323 million from the previous year)」
The wellness business posted higher revenue and profit, driven by the expansion of クリニコ, powdered milk for adults under the "Milk Life" brand, and health foods. - FY2022-Q3AdvancedAnnual report
「Wellness business revenue ¥33,824 million (up 1.9% year on year) Wellness business operating profit ¥3,302 million (up ¥259 million from the previous year)」
Wellness business revenue and operating profit increased, driven by the expansion of クリニコ, powdered milk for adults under the "Milk Life" brand, and health foods. - FY2022-Q2AdvancedAnnual report
「② Wellness business: Sales by クリニコ, powdered milk for adults as a health and nutritional supplement under the "Milk Life" brand, and health foods expanded, resulting in higher revenue.」
Driven by expanded sales of クリニコ, powdered milk for adults under the "Milk Life" brand, and health foods, wellness business revenue was ¥21,771 million, up 3.1% year on year, while operating profit was ¥1,994 million, an increase of ¥254 million from the previous year. - FY2022-Q1AdvancedAnnual report
「Sales by クリニコ, powdered milk for adults as a health and nutritional supplement under the "Milk Life" brand, and health foods expanded, resulting in higher revenue.」
Identifies expanded sales of クリニコ, powdered milk for adults under the "Milk Life" brand, and health foods, as well as higher revenue, as progress in the health and nutrition business. - FY2021-Q1AdvancedAnnual report
「In June, the company also began new initiatives, including the launch through its e-commerce channel of Japan's first yogurt that can be stored at room temperature.」
In addition to strong performance by powdered milk for adults, the company launched Japan's first shelf-stable yogurt through its e-commerce channel. - FY2020AdvancedAnnual report
「In March 2020, the company obtained manufacturing approval from the Ministry of Health, Labour and Welfare for "modified milk powder containing bifidobacteria."」
The company obtained manufacturing approval for follow-up milk containing bifidobacteria and is advancing specific product development in health and nutrition foods. It also identifies enteral nutrition, powdered milk for adults and products for medical and nursing care as areas of focus. - FY2019AdvancedAnnual report
「In the medical food field, the company developed and launched "MA-Lactophia 1.0," with an energy density of 1.0 kcal/ml, adding to the existing 0.6 kcal/ml and 0.8 kcal/ml products in the "MA-Lactophia" series, which contains three types of dietary fiber and Shield lactic acid bacteria®.」
In the health and nutrition business, the company developed and launched a new medical food product with a different energy density, advancing its product rollout. - FY2018AdvancedAnnual report
「⑥ In health and nutrition-enhancing foods, including medical foods, the company developed products to meet a wide range of needs. These included the "Ouchi no Okazu" baby food series and "Kodomiiru," a beverage supporting the growth of young children.」
The company is advancing specific product development in the health and nutrition field, including baby food, beverages for young children, nutritional supplements and beverages supporting rehabilitation. - FY2018-Q1RestatedAnnual report
「In the food industry, although some high-value-added products, including functional foods benefiting from growing health consciousness, continued to show movement, intense competition persisted as consumer prices remained flat.」
Continues to identify growth in functional foods and activity in high-value-added products as business conditions. - FY2017AdvancedAnnual report
「In the infant nutrition business, in the infant formula segment, the company progressively introduced new formulations containing biotin in response to changes in the approval standards for foods for specified health uses, as well as L-carnitine in line with international standards, and renewed its "Morinaga Hagukumi," "Morinaga E-Akachan" and "Morinaga AR Milk" products.」
The company changed the formulations of its infant formula and renewed its major products, advancing specific product development in its health and nutrition business. - FY2017-Q3RestatedAnnual report
「While some high-value-added products showed movement, including growing attention to functional foods amid increasing health consciousness, the consumer price index excluding fresh food remained flat and a challenging competitive environment continued.」
Continues to identify growing health consciousness and interest in functional foods as conditions in the food industry. No specific progress on the company's own initiatives is indicated. - FY2017-Q2RestatedAnnual report
「While some high-value-added products showed movement, including growing attention to functional foods amid increasing health consciousness, difficult conditions continued as the rise in consumer prices slowed.」
It describes growing health consciousness and attention to functional foods as factors affecting the food industry. No specific progress in the company's own initiatives is described. - FY2016First statedAnnual report
「Development of the Health and Nutrition Business」
One of the 4 business pillars in the medium-term management plan. It also describes the company's track record in developing medical foods, dietary supplements, infant and functional products, and other products.